Resistance Analysis of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir

Asunaprevir (BMS-650032) is a potent hepatitis C virus (HCV) NS3 protease inhibitor demonstrating efficacy in alfa interferon-sparing, direct-acting antiviral dual-combination regimens (together with the NS5A replication complex inhibitor daclatasvir) in patients chronically infected with HCV genoty...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: McPhee, Fiona, Friborg, Jacques, Levine, Steven, Chen, Chaoqun, Falk, Paul, Yu, Fei, Hernandez, Dennis, Lee, Min S., Chaniewski, Susan, Sheaffer, Amy K., Pasquinelli, Claudio
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2012
Materias:
Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3393445/
https://ncbi.nlm.nih.gov/pubmed/22508297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00308-12
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares